David F. Hale, Director at METABASIS THERAPEUTICS INC (MBRX), bought 13,111 shares at $2.34 ($31K) on 2008-04-16, disclosed to the SEC on 2008-04-17.
Open-market purchase of $31k MBRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.34 | 3,111 | $7K | 23.7% |
| 2 | $2.34 | 10,000 | $23K | 76.3% |
| Total | $2.34 avg | 13,111 | $31K | 100% |
| Filing → |
| ONCT | SELL | 2021-07-02 | $17K | — | Filing → |
| BIOC | SELL | 2020-06-12 | $645 | — | Filing → |
| BIOC | BUY | 2016-10-21 | $200K | — | Filing → |